Spitalul Clinic de Psihiatrie Prof. Dr. Alexandru Obregia

Bucharest 041914

3 studies enrolling now · 12 studies all time

What they study most

Agitation Associated With Alzheimer's Dementia, Anhedonia, Attention Deficit Hyperactivity Disorder, Autism, Bipolar Depression, Chronic Schizophrenia, Depressive Disorder, Major, Depressive Episodes, Bipolar I Depression, Psychosis Associated With Alzheimer's Disease, Schizophrenia

Studies at this site

• A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia — Recruiting now
• Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms — Recruiting now
• A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease — Recruiting now
• A Study of Aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms in Participants With Major Depressive Disorder Who Experience a Loss of Interest and Pleasure — Stopped early
• A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder. — Stopped early
• Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) — Completed
• Pediatric Open-Label Extension Study — Completed
• Pediatric Schizophrenia Efficacy and Safety Study — Completed
• Lurasidone Low-Dose - High-Dose Study Study — Completed
• Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia. — Completed
• Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia — Completed
• Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia — Completed